June 1968

A New Antiserotonin in the Carcinoid Syndrome

Author Affiliations

Columbus, Ohio

From the Department of Medicine, Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio. Doctor Mengel is a John and Mary R. Markle Scholar in Academic Medicine.

Arch Intern Med. 1968;121(6):507-510. doi:10.1001/archinte.1968.03640060021004

Studies of the effectiveness of a new antiserotonin agent in patients with the carcinoid syndrome are described. Five of the seven patients tested had significant and objective evidence of improvement of symptoms. The clinical usefulness of this class of agents (antiserotonin) in the management of carcinoid patients is reemphasized.